Adjuvant capecitabine in biliary tract cancer: a standard option?

被引：27
|
作者：
Malka, David [1 ]
Edeline, Julien [2 ]
机构：
[1] Univ Paris Saclay, Gustave Roussy, Dept Canc Med, Villejuif, France
[2] Ctr Eugene Marquis, Dept Med Oncol, Rennes, France
来源：
LANCET ONCOLOGY | 2019年 / 20卷 / 05期
关键词：
GEMCITABINE; CHEMOTHERAPY; TRIAL;
D O I：
10.1016/S1470-2045(19)30022-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：606 / 608
页数：4
相关论文
共 50 条
  • [21] Gemcitabine and Capecitabine as new Standard of care for adjuvant Therapy in Pancreatic Cancer
    Strobel, O.
    Buechler, M. W.
    CHIRURG, 2017, 88 (06): : 539 - 539
  • [22] Gemcitabine and Capecitabine as new Standard of care for adjuvant Therapy in Pancreatic Cancer
    Strobel, O.
    Buechler, M. W.
    CHIRURG, 2019, 90 : S86 - S86
  • [23] Adjuvant Capecitabine for Biliary Cancer and the Importance of Looking Beyond P-Values
    Fojo, Antonio Tito
    Neugut, Alfred, I
    ONCOLOGIST, 2024, 29 (02): : 102 - 105
  • [24] ADJUVANT CHEMOTHERAPY FOR RESECTED BILIARY TRACT CANCER: A RETROSPECTIVE ANALYSIS
    Caponi, S.
    Lucchesi, M.
    Vasile, E.
    Caparello, C.
    Ginocchi, L.
    Lencioni, M.
    Ricci, S.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 262 - 262
  • [25] Difficulty of adjuvant chemotherapy administration in patients with biliary tract cancer
    Tatsuaki Sumiyoshi
    Kenichiro Uemura
    Ryuta Shintakuya
    Kenjiro Okada
    Kenta Baba
    Takumi Harada
    Masahiro Serikawa
    Yasutaka Ishii
    Shinya Nakamura
    Koji Arihiro
    Yoshiaki Murakami
    Shinya Takahashi
    Langenbeck's Archives of Surgery, 408
  • [26] Difficulty of adjuvant chemotherapy administration in patients with biliary tract cancer
    Sumiyoshi, Tatsuaki
    Uemura, Kenichiro
    Shintakuya, Ryuta
    Okada, Kenjiro
    Baba, Kenta
    Harada, Takumi
    Serikawa, Masahiro
    Ishii, Yasutaka
    Nakamura, Shinya
    Arihiro, Koji
    Murakami, Yoshiaki
    Takahashi, Shinya
    LANGENBECKS ARCHIVES OF SURGERY, 2023, 408 (01)
  • [27] ROLE OF ADJUVANT CHEMORADIOTHERAPY FOR RESECTED EXTRAHEPATIC BILIARY TRACT CANCER
    Kim, Tae Hyun
    Han, Sung-Sik
    Park, Sang-Jae
    Lee, Woo Jin
    Woo, Sang Myung
    Moon, Sung Ho
    Yoo, Tae
    Kim, Sang Soo
    Kim, Seong Hoon
    Hong, Eun Kyung
    Kim, Dae Yong
    Park, Joong-Won
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : E853 - E859
  • [28] Neoadjuvant and adjuvant therapy for biliary tract cancer: Advances and limitations
    Wilbur, H. Catherine
    Soares, Heloisa P.
    Azad, Nilofer S.
    HEPATOLOGY, 2024,
  • [29] Role of adjuvant and neoadjuvant therapy for resectable biliary tract cancer
    Nara, Satoshi
    Esaki, Minoru
    Ban, Daisuke
    Takamoto, Takeshi
    Mizui, Takahiro
    Shimada, Kazuaki
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 15 (05) : 537 - 545
  • [30] ADJUBIL: phase II study of adjuvant immunotherapy with STRIDE regimen with/without capecitabine in biliary tract cancers
    Goetze, Thorsten
    Gonzalez-Carmona, Maria A.
    Kochen, Lisa
    Agaoglu, Nihat Bugra
    Al-Batran, Salah-Eddin
    Habibzada, Timorshah
    Pons, Miriam
    Brunner, Marius
    Ettrich, Thomas J.
    Koehne, Claus-Henning
    Roderburg, Christoph
    Modest, Dominik
    FUTURE ONCOLOGY, 2024, 20 (06) : 307 - 315
12345